Surge In Drug Approvals And Trials Fueling The Growth Of The Market Due To Advancements In Precision Medicine: Strengthening the Growth Trajectory of the Pharmaceutical Analytical Testing Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Pharmaceutical Analytical Testing Market Through 2025?
The market size for pharmaceutical analytical testing has experienced significant growth in recent years. It is projected to grow from $7.52 billion in 2024 to $8.21 billion in 2025 with a compound annual growth rate (CAGR) of 9.1%. The growth observed in the historical period can be tied to the increased approval of generic drugs, higher investment from pharmaceutical firms, the expansion of biologics and biosimilar products, the rising trend of personalized medicine, and growing demand for sophisticated testing methods.

What's the Projected Size of the Global Pharmaceutical Analytical Testing Market by 2029?
The market size of pharmaceutical analytical testing is anticipated to experience robust expansion in the upcoming years. It's projected to reach $11.48 billion by 2029, with a compound annual growth rate of 8.7%. The surge in this market during the predicted timeframe is due to the increasing demand for biologics and cell and gene therapies, the growth of pharmaceutical manufacturing in emerging markets, the increasing intricacy of new drug molecules, the rise in outsourcing analytical services to CROs, and a burgeoning pipeline of orphan and rare disease drugs. Throughout the forecasting period, key trends include the utilization of artificial intelligence for data analysis, real-time release testing (RTRT), the use of automation and robotics in QC labs, cloud-based systems for laboratory information management, increased automation and digitization, and the adoption of real-time analytics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-analytical-testing-global-market-report

Top Growth Drivers in the Pharmaceutical Analytical Testing Industry: What's Accelerating the Market?
The anticipated progression of the pharmaceutical analytical testing market is linked to the increasing number of drug approvals and trials. The latter entails a meticulously regulated procedure that involves the testing of novel medications through clinical trials to ascertain their safety and effectiveness, which is then followed by the necessary authorization by health bodies for public usage. The escalation in drug approvals and trials can be traced back to the progression of precision medicine, which enables the creation of extremely specific treatments that cater to distinct genetic profiles, thereby heightening the probability of efficacy and regulatory triumph. Pharmaceutical analytical testing plays a crucial role in drug approvals and clinical trials, as it guarantees the safety, efficacy, and quality of drug products by furnishing validated knowledge about stability, impurities, bioavailability, and pharmacokinetics, all of which bolster regulatory adherence and informed decision-making. For instance, a report from the Association of the British Pharmaceutical Industry (ABPI), a non-profit association headquartered in the UK, stated in November 2023 that the total count of yearly industry clinical trials instigated in the UK saw a slight escalation of 4.3%, going from 394 trials in 2021 to 411 in 2022. As a result, the increased number of drug approvals and trials is contributing to the growth of the pharmaceutical analytical testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27378&type=smp

What Trends Will Shape the Pharmaceutical Analytical Testing Market Through 2029 and Beyond?
Key players in the pharmaceutical analytical testing market are prioritizing the projection of innovative solutions like digital reference materials platforms. These innovations aim to increase laboratory testing processes' accuracy, traceability, and efficiency, ensuring regulatory compliance and boosting data integrity quality. Digital reference materials platforms are online or software-anchored systems that offer validated, standardized digital data sets or models for calibrating, authenticating, and checking analytical testing processes in pharmaceutical labs. Merck Group, a German-based pharmaceutical company, introduced a pioneering digital reference materials platform called ChemisTwin in November 2023, designed for analytical testing. ChemisTwin utilizes calibrated, digital references based on algorithms to automate sample purity analysis, compound identification, and degradation. With digital signatures for over 1,500 reference materials, ChemisTwin speeds up workflows in pharmaceutical quality control, quality assurance, research and development while providing traceable digital records linked with physical reference materials. This cutting-edge platform mitigates manual tasks like weighing and documenting, increases sampling rates, and enhances the detection of sample inconsistencies, making products safer and more reliable.

What Are the Main Segments in the Pharmaceutical Analytical Testing Market?
The pharmaceutical analytical testing market covered in this report is segmented

1) By Service Type: Bioanalytical Testing, Method Development And Validation, Stability Testing, Drug Substances Testing, Microbial Testing, Physical Characterization, Other Service Types
2) By Technique Used: Chromatography, Spectroscopy, Mass Spectrometry, Electrophoresis, Microscopy
3) By Application: Quality Control, Research And Development, Regulatory Compliance, Drug Approval And Registration, Post-Marketing Surveillance
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Academic Institutions, Regulatory Bodies, Testing Laboratories

Subsegments:
1) By Bioanalytical Testing: Pharmacokinetics Testing, Biomarker Testing, Immunogenicity Testing, Toxicokinetics Testing
2) By Method Development And Validation: Analytical Method Development, Analytical Method Validation, Method Transfer
3) By Stability Testing: Long-Term Stability Testing, Accelerated Stability Testing, Stress Stability Testing, Photostability Testing
4) By Drug Substances Testing: Raw Material Testing, Intermediate Testing, Final Drug Substance Testing
5) By Microbial Testing: Bioburden Testing, Sterility Testing, Endotoxin Testing, Microbial Limit Testing
6) By Physical Characterization: Particle Size Analysis, Polymorphism Analysis, Rheology Testing, Thermal Analysis
7) By Other Service Types: Impurity Testing, Elemental Impurity Testing, Extractables And Leachables Testing, Packaging Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27378&type=smp

Which Top Companies are Driving Growth in the Pharmaceutical Analytical Testing Market?
Major companies operating in the pharmaceutical analytical testing market are Thermo Fisher Scientific Inc., Merck KGaA, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Ajinomoto Co. Inc., ICON Public Limited Company, Eurofins Scientific SE, Pharmaceutical Product Development LLC, WuXi AppTec Co. Ltd., Syneos Health Inc., Steris plc, Catalent Inc., Charles River Laboratories International Inc., Intertek Group plc, AptarGroup Inc., West Pharmaceutical Services Inc., SGS Société Générale de Surveillance SA, Almac Group Limited, Pace Analytical Services LLC, Neotron S.p.A., Toxikon Corporation, Element Materials Technology Group Limited, and Boston Analytical Inc.

Which Regions Will Dominate the Pharmaceutical Analytical Testing Market Through 2029?
North America was the largest region in the pharmaceutical analytical testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical analytical testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27378

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.